Orbus Therapeutics
Palo Alto
About Orbus Therapeutics
They at Orbus are committed to bringing innovative products to the extremely underserved patients affected by rare diseases. They are focused and passionate about bringing a more positive outcome to patients facing life-threatening or significantly life-altering diseases. Currently, Orbus Therapeutics is working to develop and commercialize eflornithine in North America. The company was founded in 2012 and is headquartered in Palo Alto, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $55.0M
- Last round: Series Unknown (Aug 2020)
- Website: orbustherapeutics.com
- Phone: 650-656-9440
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/orbus-therapeutics-78306 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.